Anika To Participate in 43rd Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Anika Therapeutics (NASDAQ: ANIK), a global joint preservation company specializing in early intervention orthopedics, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. Dr. Cheryl Blanchard, President and CEO, will deliver a presentation on Thursday, January 16, 2025, at 9:45am PT / 12:45pm ET in San Francisco.

The presentation will be accessible via live webcast on the Events and Webcasts page in the Investors section of Anika's website, remaining available for 30 days afterward. The company's management team will also engage in one-on-one investor meetings throughout the event. Interested parties can arrange meetings through Anika's Investor Relations.

News Market Reaction – ANIK

+0.62%

+0.62% Session move

In the trading session that priced this news, ANIK gained 0.62%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BEDFORD, Mass., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that Dr. Cheryl Blanchard, President and CEO of Anika, will present at the 43^rd Annual J.P. Morgan Healthcare Conference in San Francisco on Thursday, January 16, 2025 at 9:45am PT / 12:45pm ET. Management will also participate in one-on-one investor meetings throughout the event.

The presentation will be webcast live on the Events and Webcasts page under the Investors section of Anika Therapeutics’ website and will be archived for 30 days following the presentation. For more information about this event or to schedule a one-on-one meeting with Anika’s senior management, please contact Anika’s Investor Relations at investorrelations@anika.com.

About Anika
Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Leveraging our core expertise in hyaluronic acid and implant solutions, we partner with clinicians to provide minimally invasive products that restore active living for people around the world. Our focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management and Regenerative Solutions, and our products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika’s global operations are headquartered outside of Boston, Massachusetts. For more information about Anika, please visit www.anika.com.

ANIKA, ANIKA THERAPEUTICS, CINGAL, HYALOFAST, INTEGRITY, MONOVISC, ORTHOVISC, TACTOSET, and the Anika logo are trademarks of Anika Therapeutics, Inc. or its subsidiaries or are licensed to Anika Therapeutics, Inc. for its use.

For Investor Inquiries:
Anika Therapeutics, Inc.
Matt Hall, 781-457-9554
Director, Corporate Development and Investor Relations
investorrelations@anika.com

FAQ

When is Anika Therapeutics (ANIK) presenting at the 2025 J.P. Morgan Healthcare Conference?

Anika Therapeutics will present on Thursday, January 16, 2025, at 9:45am PT / 12:45pm ET.

How can investors watch Anika's (ANIK) J.P. Morgan Healthcare Conference presentation?

The presentation will be available via live webcast on the Events and Webcasts page under the Investors section of Anika Therapeutics' website.

How long will Anika's (ANIK) J.P. Morgan Conference presentation recording be available?

The presentation recording will be archived and available for 30 days following the presentation.

How can investors schedule one-on-one meetings with Anika (ANIK) management at the J.P. Morgan Conference?

Investors can schedule one-on-one meetings by contacting Anika's Investor Relations at investorrelations@anika.com.